ARTV
Artiva Biotherapeutics, Inc.
7.50$
-3.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | +146.3% | +579.2% | -99.3% | -100.0% | |
| – | – | – | – | – | – | |
| – | – | +146.3% | +579.2% | -99.3% | -1,134.7% | |
| – | +206.3% | +3.7% | +14.2% | +0.2% | +38.2% | |
| – | +190.6% | +61.5% | -33.0% | +23.7% | +17.8% | |
| – | +202.5% | +17.2% | -0.9% | +5.3% | +30.3% | |
| – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | |
| – | – | – | – | – | – | |
| – | -2,844.5% | – | +35.8% | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.